 | • レポートコード：MRC2305C129 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、239ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に3,777.80百万ドルであった世界の胎児モニタリング市場規模が、2022年には4,088.79百万ドルに成長し、その後年平均8.40％拡大して2027年には6,132.37百万ドルに達すると予測しています。本調査資料では、胎児モニタリングの世界市場について総合的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（付属品＆消耗品、電子母子モニター、胎児用ドップラー装置、胎児用電極、テレメトリーデバイス）分析、方法別（侵襲的方法、非侵襲的方法）分析、用途別（産前、分娩中）分析、エンドユーザー別（在宅医療、病院、産婦人科クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめました。なお、本書内の企業情報には、Advanced Instrumentations (US)、Bionet Co., Ltd. (South Korea)、BISTOS (Korea)、BRAEL-Medical Equipment (Poland)、Cardinal Health, Inc. (US)、ChoiceMMed (China)、CONTEC Medical Systems Co., Ltd. (China)、Dixion (Germany)、Dott Medical Co. Ltd. (China)、EDAN Diagnostics, Inc. (China)などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の胎児モニタリング市場規模：製品別 - 付属品＆消耗品の市場規模 - 電子母子モニターの市場規模 - 胎児用ドップラー装置の市場規模 - 胎児用電極の市場規模 - テレメトリーデバイスの市場規模 ・世界の胎児モニタリング市場規模：方法別 - 侵襲的方法の市場規模 - 非侵襲的方法の市場規模 ・世界の胎児モニタリング市場規模：用途別 - 産前胎児モニタリングの市場規模 - 分娩中胎児モニタリングの市場規模 ・世界の胎児モニタリング市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院における市場規模 - 産婦人科クリニックにおける市場規模 ・世界の胎児モニタリング市場規模：地域別 - 南北アメリカの胎児モニタリング市場規模 アメリカの胎児モニタリング市場規模 カナダの胎児モニタリング市場規模 ブラジルの胎児モニタリング市場規模 ... - アジア太平洋の胎児モニタリング市場規模 日本の胎児モニタリング市場規模 中国の胎児モニタリング市場規模 インドの胎児モニタリング市場規模 韓国の胎児モニタリング市場規模 台湾の胎児モニタリング市場規模 ... - ヨーロッパ/中東/アフリカの胎児モニタリング市場規模 イギリスの胎児モニタリング市場規模 ドイツの胎児モニタリング市場規模 フランスの胎児モニタリング市場規模 ロシアの胎児モニタリング市場規模 ... - その他地域の胎児モニタリング市場規模 ・競争状況 ・企業情報 |
The Global Fetal Monitoring Market size was estimated at USD 3,777.80 million in 2021 and expected to reach USD 4,088.79 million in 2022, and is projected to grow at a CAGR 8.40% to reach USD 6,132.37 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Fetal Monitoring to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Accessories And Consumables, Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Fetal Electrodes, Telemetry Devices, Ultrasound Devices, and Uterine Contraction Monitors.
Based on Portability, the market was studied across Non-Portable Systems and Portable Systems.
Based on Method, the market was studied across Invasive Method and Noninvasive Method.
Based on Application, the market was studied across Antepartum and Intrapartum.
Based on End User, the market was studied across Home Care Settings, Hospitals, and Obstetrics & Gynecology Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Fetal Monitoring market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Fetal Monitoring Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fetal Monitoring Market, including Advanced Instrumentations (US), Bionet Co., Ltd. (South Korea), BISTOS (Korea), BRAEL-Medical Equipment (Poland), Cardinal Health, Inc. (US), ChoiceMMed (China), CONTEC Medical Systems Co., Ltd. (China), Dixion (Germany), Dott Medical Co. Ltd. (China), EDAN Diagnostics, Inc. (China), FUJIFILM SonoSite, Inc. (US), GE Healthcare (US), GPC Medical (India), Huntleigh Healthcare Limited (UK), Koninklijke Philips N.V. (Netherlands), Life Plus (India), MedGyn Products, Inc (US), Mediana (Korea), Monarch Meditech (India), Natus Medical Incorporated (US), Neoventa Medical AB (Sweden), Progetti Srl (Italy), Promed Group Co., Ltd. (Hong Kong), Shenzhen Comen Medical Instruments Co., Ltd. (China), ShenZhen Luckcome Technology Inc. (China), Siemens Healthineers (Germany), The Cooper Companies Inc. (US), TRISMED Co., Ltd. (Republic of Korea), and Trivitron Healthcare (India).
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Fetal Monitoring Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Fetal Monitoring Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Fetal Monitoring Market?
4. What is the competitive strategic window for opportunities in the Global Fetal Monitoring Market?
5. What are the technology trends and regulatory frameworks in the Global Fetal Monitoring Market?
6. What is the market share of the leading vendors in the Global Fetal Monitoring Market?
7. What modes and strategic moves are considered suitable for entering the Global Fetal Monitoring Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in birth rates & preterm births worldwide
5.1.1.2. Government initiatives and awareness for better fetal care
5.1.1.3. High adoption for fetal heart monitoring
5.1.2. Restraints
5.1.2.1. Accuracy concerns
5.1.2.2. Technological limitations and subjective interpretations
5.1.3. Opportunities
5.1.3.1. Wearable technology devices for fetal monitoring
5.1.3.2. Rising preferences for non-invasive fetal monitoring
5.1.4. Challenges
5.1.4.1. Often difficulties in finding and counting fetal heart rate
5.2. Cumulative Impact of COVID-19
6. Fetal Monitoring Market, by Product
6.1. Introduction
6.2. Accessories And Consumables
6.3. Electronic Maternal/Fetal Monitors
6.4. Fetal Doppler Devices
6.5. Fetal Electrodes
6.6. Telemetry Devices
6.7. Ultrasound Devices
6.8. Uterine Contraction Monitors
7. Fetal Monitoring Market, by Portability
7.1. Introduction
7.2. Non-Portable Systems
7.3. Portable Systems
8. Fetal Monitoring Market, by Method
8.1. Introduction
8.2. Invasive Method
8.3. Noninvasive Method
9. Fetal Monitoring Market, by Application
9.1. Introduction
9.2. Antepartum
9.3. Intrapartum
10. Fetal Monitoring Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospitals
10.4. Obstetrics & Gynecology Clinics
11. Americas Fetal Monitoring Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Fetal Monitoring Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Fetal Monitoring Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Advanced Instrumentations (US)
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Bionet Co., Ltd. (South Korea)
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. BISTOS (Korea)
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. BRAEL-Medical Equipment (Poland)
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Cardinal Health, Inc. (US)
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. ChoiceMMed (China)
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. CONTEC Medical Systems Co., Ltd. (China)
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Dixion (Germany)
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Dott Medical Co. Ltd. (China)
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. EDAN Diagnostics, Inc. (China)
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. FUJIFILM SonoSite, Inc. (US)
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. GE Healthcare (US)
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. GPC Medical (India)
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Huntleigh Healthcare Limited (UK)
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Koninklijke Philips N.V. (Netherlands)
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Life Plus (India)
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. MedGyn Products, Inc (US)
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Mediana (Korea)
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Monarch Meditech (India)
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Natus Medical Incorporated (US)
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Neoventa Medical AB (Sweden)
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Progetti Srl (Italy)
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
15.23. Promed Group Co., Ltd. (Hong Kong)
15.23.1. Business Overview
15.23.2. Key Executives
15.23.3. Product & Services
15.24. Shenzhen Comen Medical Instruments Co., Ltd. (China)
15.24.1. Business Overview
15.24.2. Key Executives
15.24.3. Product & Services
15.25. ShenZhen Luckcome Technology Inc. (China)
15.25.1. Business Overview
15.25.2. Key Executives
15.25.3. Product & Services
15.26. Siemens Healthineers (Germany)
15.26.1. Business Overview
15.26.2. Key Executives
15.26.3. Product & Services
15.27. The Cooper Companies Inc. (US)
15.27.1. Business Overview
15.27.2. Key Executives
15.27.3. Product & Services
15.28. TRISMED Co., Ltd. (Republic of Korea)
15.28.1. Business Overview
15.28.2. Key Executives
15.28.3. Product & Services
15.29. Trivitron Healthcare (India)
15.29.1. Business Overview
15.29.2. Key Executives
15.29.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing